UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medical device makers to fight bias against homemade products
“We want to raise our local market share to 70 percent, global market share...
by Jeong Sae-im
|
2019-08-20 12:50
라인
Genexine, Toolgen merger deal falls through
Genexine said Tuesday it has revoked the merger agreement with Toolgen beca...
by Lee Han-soo
|
2019-08-20 11:21
라인
Number of drug addicts reached 77,000 in past 5 years
Drug abuse is emerging as a serious problem in Korea with the number of dru...
by Lee Han-soo
|
2019-08-19 18:00
라인
Breast implant recipients to file class-action suit against Allergan
Koreans who received breast implants using Allergan’s specific product are ...
by Song Soo-youn
|
2019-08-19 16:05
라인
Combo drugs: latest trend in local pharmaceuticals
Domestic pharmaceutical companies are actively developing combination drugs...
by Lee Hye-seon
|
2019-08-19 16:02
라인
‘Surgery is better than hormone therapy for prostate cancer patients’
Researchers at St. Mary’s Seoul Hospital have discovered that surgical trea...
by Lee Han-soo
|
2019-08-19 16:00
라인
Boryung to sell antihypertensive drugs in Mexico
Boryung Pharmaceutical said the company would sell its antihypertensive com...
by Lee Han-soo
|
2019-08-19 14:31
라인
Rivalry among PARP inhibitors intense in ovarian cancer treatment
Pharmaceutical firms’ war using PARP inhibitors, a group of pharmacological...
by Kim Yun-mi
|
2019-08-19 14:00
라인
Pharmicell submits new drug application for ovarian cancer treatment
Pharmicell said that it has filed an investigational new drug application t...
by Lee Han-soo
|
2019-08-19 13:10
라인
Stock exchange names Kolon Life Science as administrative issue
Kolon Life Science, once one of the most promising bio-stocks, has been dow...
by Lee Han-soo
|
2019-08-16 16:49
라인
Medipost’s stem cell therapy, cord blood bank show solid growth
Medipost’s stem cell therapy Cartistem for osteoarthritis and umbilical cor...
by Jeong Sae-im
|
2019-08-16 16:18
라인
Rare cancer reported in Korea regarding Allergan’s breast implant
The health authorities said here they have received the first report of bre...
by Lee Hye-seon
|
2019-08-16 14:54
라인
SMC finds method to eliminate complications during temporal lobe epilepsy surgery
Researchers at Samsung Medical Center (SMC) have discovered that intraopera...
by Lee Han-soo
|
2019-08-16 14:52
라인
Local drugmakers speed up NASH drug development
Domestic pharmaceutical companies are rushing to develop a treatment for no...
by Lee Hye-seon
|
2019-08-16 13:52
라인
Theragen Etex turns profitable after marking record Q2 sales
Theragen Etex said Tuesday that the company and its subsidiaries recorded c...
by Lee Han-soo
|
2019-08-14 17:22
라인
AstraZeneca wins expanded indication for type 2 diabetes treatment Forxiga
AstraZeneca said that it has received an expanded indication approval for F...
by Lee Han-soo
|
2019-08-14 16:17
라인
Korea to provide ₩100 billion annually for 3 new industries
The government said it would prove more than 100 billion won ($82.4 million...
by Song Soo-youn
|
2019-08-14 14:52
라인
Korean firms eyeing on growing orphan drug market
Investigational drugs developed by Korean pharmaceutical companies are incr...
by Jeong Sae-im
|
2019-08-14 14:48
라인
Huons Global hits record-high 1H sales
Huons Global said Wednesday the company and its subsidiaries recorded 209.6...
by Lee Han-soo
|
2019-08-14 14:46
라인
Court dismisses Kolon's petition to suspend government's step on Invossa
A local court has rejected a petition made by Kolon Life Science to suspend...
by Lee Han-soo
|
2019-08-14 11:57
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top